CASI लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 20:52):
Our systems believe the stock currently is undervalued by 0.05% compare to its pairs and should correct upwards.

CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally...

Stats
आज की मात्रा	11 378
औसत मात्रा	31 332
बाजार मूल्य	47.84M
EPS	$-0.710 ( Q1 \| 2024-03-31 )
अगली कमाई की तारीख	( $-0.630 ) 2024-08-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.570 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0620 (1.74%)

AADI -2.65%

ABCL 1.79%

ABCM 0.04%

ABEO -2.84%

ABIO -1.68%

ABOS 1.64%

ABSI 2.89%

ABUS -2.24%

ABVX -3.53%

ACAD -0.71%

ACER -17.95%

ACET -4.73%

ACGN 1.29%

ACHL -4.15%

ACHV -1.83%

ACIU -0.50%

ACLX -0.13%

ACRV -4.79%

ACST -1.63%

ACXP 0.65%

ADAG 4.64%

ADAP -2.79%

ADGI 0.87%

ADIL 0.54%

ADMA -2.50%

ADPT -0.15%

ADTX -3.47%

ADVM -3.18%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -1.40%

AGEN -1.88%

AGIO -1.88%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.48%

AKRO -2.77%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.11%

ALEC -3.90%

ALGS -2.41%

ALKS -0.21%

ALLK -8.90%

ALLO -6.28%

ALLR -4.09%

ALNA 3.16%

ALNY 1.69%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -9.45%

ALVR 0.93%

ALXN 0.00%

ALXO -10.43%

ALZN 4.78%

AMRN 0.26%

AMTI -3.13%

ANAB 0.80%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.65%

ANPC -3.15%

APGE -0.99%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.02%

APLT -3.94%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 4.70%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -3.89%

ARDS -14.23%

ARDX -0.91%

ARGX -0.80%

ARNA 0.00%

ARPO -0.90%

ARQT -0.47%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.23%

ARWR -1.77%

ASLN -3.44%

ASMB -5.19%

ASND -0.91%

ATAI -1.46%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.99%

ATOS 3.40%

ATRA -2.89%

ATXI 1.93%

ATXS -1.22%

AUPH -0.99%

AURA -0.15%

AUTL -1.87%

AVBP -2.86%

AVEO 0.00%

AVIR -0.15%

AVRO -1.41%

AVTE -4.86%

AVTX -1.25%

AVXL -2.59%

AXLA 0.00%

AXSM -1.73%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.73%

BCAB 3.59%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 2.60%

BCRX 1.40%

BCTX 8.12%

BCTXW -22.14%

BCYC 0.55%

BDRX -5.18%

BDTX -0.85%

BEAM 0.08%

BFRA -2.91%

BGNE -2.19%

BIOR -3.40%

BIVI 0.56%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.54%

BMEA -9.47%

BMRN 0.39%

BNOX -2.22%

BNTC -2.11%

BNTX -1.21%

BOLD -7.90%

BOLT -0.18%

BPMC -1.15%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 23.77%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.33%

CABA 0.90%

CADL -1.15%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -2.80%

CARA -0.62%

CARM 12.13%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.94%

CCCC -5.30%

CCXI 0.00%

CDAK 0.00%

CDIO -2.02%

CDIOW 24.00%

CDMO -2.82%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.00%

CDXS 4.31%

CELC -3.82%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -0.81%

CERO -3.60%

CEROW -10.18%

CFRX -27.95%

CGEM -2.74%

CGEN -3.31%

CGON -0.32%

CGTX -4.55%

CHMA -6.00%

CHRS -0.63%

CINC 0.00%

CING 0.68%

CINGW 34.95%

CKPT -2.88%

CLBS -16.75%

CLDX -2.32%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.41%

CLSD -2.90%

CLSN -0.68%

CLVS 0.00%

CMMB -0.01%

CMND 3.63%

CMPI 0.00%

CMPX -8.03%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -40.07%

CNST 0.00%

CNTA -1.12%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -3.00%

CORT 2.14%

COYA -1.46%

CPRX -0.86%

CRBP -1.85%

CRBU -5.10%

CRDF -2.21%

CRGX 1.28%

CRIS -0.38%

CRNX -5.84%

CRSP 1.07%

CRTX 2.63%

CRVO -2.50%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -3.31%

CTNM -2.13%

CTXR 1.03%

CUE 3.63%

CVAC -1.98%

CVKD 0.15%

CWBR 2.80%

CYAD -12.96%

CYCC 9.84%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -2.04%

CYTO -2.73%

DARE 6.54%

DAWN 0.30%

DBTX -0.81%

DBVT -2.08%

DFFN 10.28%

DICE 0.06%

DMAC 34.97%

DNLI -1.88%

DNTH -6.35%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.51%

DTIL 0.89%

DYAI 9.68%

EARS -1.77%

EDIT -2.42%

EDSA -1.00%

EFTR 7.18%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -4.56%

ELOX 7.69%

ELTX -0.88%

ELVN -4.52%

ELYM 0.77%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 5.11%

ENTA -0.49%

ENTO -0.07%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.51%

ETON -0.30%

ETTX 0.00%

EVAX -2.14%

EVGN 6.35%

EVLO 0.00%

EWTX 0.03%

EXAI -0.95%

EXEL -0.25%

EYEG -0.69%

EYEN 1.51%

EYPT -0.12%

FATE -7.93%

FBIO 0.59%

FBIOP 0.92%

FBLG -16.60%

FBRX -0.04%

FDMT -4.77%

FENC -1.29%

FGEN -4.70%

FHTX 1.43%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.48%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.36%

FULC -3.34%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.31%

GANX -1.42%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.76%

GHRS -1.94%

GLMD -2.15%

GLPG -2.30%

GLSI 2.80%

GLTO -0.57%

GLUE -1.58%

GLYC -10.03%

GMAB -0.47%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.52%

GNLX 0.88%

GNPX 0.98%

GNTA 3.94%

GOSS -7.82%

GOVX 5.45%

GOVXW -49.04%

GPCR -6.98%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.32%

GRTX 0.00%

GTHX 0.68%

GUTS -5.31%

GXGXW 41.67%

GYRE -7.08%

HALO -0.80%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -1.91%

HOOK 1.13%

HOTH -2.70%

HOWL -2.14%

HRMY 0.85%

HRTX 1.97%

HSTO 0.00%

HUMA 1.22%

HUMAW -0.01%

IBRX -4.13%

ICCC 0.22%

ICPT 0.21%

ICU 18.15%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.47%

IFRX -2.66%

IGMS -0.11%

IKNA 0.00%

IKT 1.42%

IMAB -0.87%

IMCR -2.60%

IMGN 0.02%

IMGO 0.00%

IMMP 4.55%

IMMX -7.76%

IMNM -1.65%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.84%

IMTX -1.58%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.73%

INAB 0.59%

INBX 0.00%

INCY -0.87%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -2.20%

INMB 2.66%

INO -1.56%

INSM -0.82%

INTS -2.75%

INVA 0.22%

INZY 0.92%

IOBT -11.02%

IONS 0.07%

IOVA -2.37%

IPA 2.46%

IPHA 5.58%

IPSC -1.95%

IRON -2.35%

ISEE 0.38%

ITOS -1.57%

ITRM 1.67%

IVA 6.96%

IVVD -3.72%

JAGX 1.04%

JANX -4.27%

JAZZ -0.40%

JNCE 0.00%

JSPR -5.93%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -1.91%

KDNY 0.22%

KMPH -0.34%

KNSA -2.68%

KNTE -0.38%

KOD -7.09%

KPRX 0.96%

KPTI -1.37%

KRBP -10.00%

KRON 1.05%

KROS -1.18%

KRRO -6.34%

KRTX 0.03%

KRYS -0.79%

KTRA 16.33%

KTTA 8.16%

KTTAW 0.92%

KURA -1.81%

KYMR -2.22%

KYTX -3.49%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -0.89%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.68%

LENZ -4.02%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -9.04%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.66%

LPCN -5.03%

LPTX -1.11%

LQDA -0.24%

LRMR -1.92%

LSTA -4.06%

LTRN 0.25%

LUMO -1.32%

LVTX 0.00%

LXEO -4.83%

LXRX -2.06%

LYEL -35.45%

LYRA 3.02%

MACK 0.10%

MBIO -9.40%

MBRX -1.72%

MCRB 1.12%

MDGL -2.35%

MDNA -13.16%

MDWD 0.10%

MDXG -2.58%

MEIP -0.13%

MESO -1.78%

MGNX -2.81%

MGTA -7.74%

MGTX -2.70%

MGX -2.68%

MIRM -1.42%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.76%

MLYS -5.55%

MNKD -0.96%

MNMD 0.21%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.06%

MORF -4.03%

MREO -4.42%

MRKR 2.68%

MRNA -4.68%

MRNS -4.04%

MRSN -2.62%

MRTX -0.17%

MRUS 0.25%

MRVI -1.97%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -1.08%

MYMD 8.38%

NAMS 1.37%

NAMSW 0.43%

NAUT 1.14%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.87%

NEXI 2.60%

NGM -1.28%

NGNE -1.40%

NKGN 5.88%

NKGNW 8.00%

NKTR -3.27%

NKTX -4.40%

NLSP -2.77%

NLSPW 26.67%

NMRA -0.80%

NMTR -42.97%

NOVN -24.84%

NRBO 12.16%

NRIX -0.62%

NRSN -3.63%

NRSNW 0.00%

NRXP -5.39%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.13%

NTRBW -31.07%

NUVL -1.93%

NVAX -1.86%

NVCT 3.59%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.40%

OABIW -10.06%

OBIO -3.21%

OBSV 0.00%

OCEA 0.00%

OCGN 4.26%

OCS -1.02%

OCUL -1.90%

OCUP 1.97%

ODT -4.27%

OKYO 1.51%

OLMA -5.12%

OMER -0.90%

OMGA 5.41%

ONCO 4.90%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 1.03%

ORGS -4.53%

ORIC -3.56%

ORMP 15.13%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.43%

OYST 0.00%

PALI -0.87%

PASG -1.30%

PBLA -7.50%

PBM -7.49%

PBYI 1.69%

PCSA 0.00%

PCVX -0.42%

PDSB -0.79%

PEPG 0.48%

PGEN -3.59%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -3.57%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.73%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT 0.28%

PRAX 0.63%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.45%

PRQR -0.01%

PRTA -2.36%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.11%

PSTX -1.35%

PTCT -0.27%

PTE -0.82%

PTGX -1.47%

PTIXW -49.04%

PULM 2.62%

PXMD 0.00%

PYPD 0.07%

PYXS 2.94%

QLGN -3.72%

QNCX 5.70%

QNRX 0.37%

QSI -11.89%

QSIAW -3.13%

QTTB -4.54%

QURE -0.22%

RAIN -1.63%

RANI 6.42%

RAPT -2.92%

RARE 1.26%

RCKT -8.09%

REGN -0.66%

RENB -3.41%

REPL -2.50%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -4.91%

RGNX -5.19%

RIGL -3.29%

RLAY -4.39%

RLMD 0.33%

RLYB -0.34%

RNA -0.36%

RNAC -5.65%

RNAZ -0.96%

RNXT 1.88%

ROIV -2.08%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.32%

RPTX -2.05%

RUBY 2.70%

RVLP -32.05%

RVMD -1.15%

RVMDW -30.00%

RVNC 1.92%

RVPH -1.19%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.36%

RYTM -6.25%

RYZB 0.02%

RZLT 1.29%

SABS -1.37%

SABSW -11.81%

SAGE 1.47%

SANA -4.15%

SAVA -0.26%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH -0.50%

SCPS 0.00%

SEEL -4.09%

SEER -0.44%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.23%

SGMT -1.93%

SGTX -2.56%

SIOX 22.63%

SLDB -5.00%

SLGL 4.00%

SLN -4.21%

SLNO -2.71%

SLRX 5.23%

SLS -2.99%

SMMT -2.62%

SNDX 0.77%

SNGX -3.02%

SNPX -0.81%

SONN -1.08%

SPPI -0.49%

SPRB 0.30%

SPRC -4.17%

SPRO 0.04%

SRNE -34.00%

SRPT -1.32%

SRRA 0.00%

SRRK -2.48%

SRZN -2.45%

STAB 0.00%

STOK -4.87%

STRO -2.51%

STSA 0.00%

STTK -4.78%

SURF -0.93%

SVRA -2.90%

SWTX 0.33%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -8.06%

TARS 0.08%

TBPH 0.48%

TCBP 2.74%

TCDA 0.00%

TCON -2.43%

TCRR 0.00%

TCRT 1.59%

TCRX 2.58%

TECH -0.07%

TENX -1.27%

TERN -6.62%

TFFP -3.05%

TGTX -2.66%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -4.13%

TNGX -2.16%

TNXP -5.98%

TNYA -8.91%

TPST 2.93%

TRDA -3.86%

TRVI 1.15%

TRVN 5.02%

TSHA -23.74%

TSVT -3.06%

TTNP -9.27%

TVTX 0.63%

TYRA -8.19%

UBX -2.12%

UNCY -3.38%

URGN -1.28%

UTHR -0.25%

VACC 11.36%

VALN -2.89%

VAXX 87.50%

VBIV 0.78%

VBLT -8.77%

VCEL -0.09%

VCNX 10.35%

VCYT -1.27%

VERA -2.80%

VERU 0.78%

VERV -2.58%

VIGL 5.11%

VINC 1.62%

VIR 0.76%

VIRI -1.61%

VIRX 2.38%

VKTX -1.05%

VLON -13.04%

VNDA -2.43%

VOR -2.41%

VRCA 0.28%

VRDN -4.15%

VRNA -1.08%

VRPX 0.38%

VRTX 0.33%

VSTM -3.40%

VTGN -0.46%

VTVT -2.97%

VTYX -0.21%

VXRT -2.26%

VYGR -1.66%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.40%

XBIO 0.93%

XBIT -0.10%

XCUR 3.58%

XENE -3.11%

XERS 2.38%

XFOR 3.72%

XLO 1.58%

XLRN 0.00%

XNCR 0.05%

XOMA -3.14%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.92%

YMAB -1.63%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.24%

ZNTL -2.86%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2022-09-07	Zukiwski Alexander A	Buy	3 000	Employee Stock Option (Right to Buy)
2022-09-06	Huang James	Buy	33 300	Common Stock
2022-08-31	Huang James	Buy	400	Common Stock
2022-08-24	Huang James	Buy	39 527	Common Stock
2022-08-19	Huang James	Buy	40 000	Common Stock

INSIDER POWER
100.00
Last 95 transactions
Buy: 27 815 562 \| Sell: 9 916 643

सहसंबंध (AI algo v.1.1b): Undervalued: 0.05% $3.57 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

CASI Pharmaceuticals Inc सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
TTEC	0.951
UONEK	0.944
CNXC	0.938
UONE	0.935
OFS	0.935
RETO	0.93
TWKS	0.929
ARKO	0.928
NEPH	0.928
AMPH	0.926

10 सबसे अधिक नकारात्मक सहसंबंध
OZEM	-1
MNMD	-0.94
BKHAR	-0.94
ROOT	-0.929
RNA	-0.929
ARYD	-0.924
BNR	-0.923
DXPE	-0.92
FANG	-0.92
AIRG	-0.919

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

CASI Pharmaceuticals Inc वित्तीय

Annual	2023
राजस्व:	$33.88M
सकल लाभ:	$18.98M (56.03 %)
EPS:	$-2.02

FY	2023
राजस्व:	$33.88M
सकल लाभ:	$18.98M (56.03 %)
EPS:	$-2.02

FY	2022
राजस्व:	$43.11M
सकल लाभ:	$27.28M (63.28 %)
EPS:	$-2.89

FY	2021
राजस्व:	$30.17M
सकल लाभ:	$17.61M (58.38 %)
EPS:	$-0.332

Financial Reports:

No articles found.

CASI Pharmaceuticals Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

CASI Pharmaceuticals Inc

CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T investigative product for the treatment of patients with B-cell acute lymphoblastic leukemia (B-ALL) and B-cell non-Hodgkin lymphoma (B-NHL); BI-1206 that is in Phase I/II trial in combination with anti-PD1 therapy Keytruda for solid tumors, and in a Phase I/IIa trial in combination with MabThera (rituximab) in patients with relapsed/refractory NHL; and CB-5339, which is in Phase I clinical trial for acute myeloid leukemia and myelodysplastic syndrome. Its product pipeline also comprises CID-103 for the treatment of patients with multiple myeloma; Thiotepa, which has multiple indications including use as a conditioning treatment for various allogeneic haemopoietic stem cell transplants; and Octreotide long acting injectable formulations for the treatment of acromegaly and for the control of symptoms associated with various neuroendocrine tumors. The company has licensing agreements with Juventas Cell Therapy Ltd; BioInvent International AB; Black Belt Therapeutics Limited; and Cleave Therapeutics, Inc. It also has distribution agreements with China Resources Pharmaceutical Commercial Group International Trading Co., Ltd; Pharmathen Global BV; and Riemser Pharma GmbH. The company was formerly known as EntreMed, Inc. and changed its name to CASI Pharmaceuticals, Inc. in June 2014. CASI Pharmaceuticals, Inc. was incorporated in 1991 and is based in Rockville, Maryland.